Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

Elevance HealthELV

Elevance Health 8-K

Filing date ·

Elevance Health said operating revenue for Q3 2026 was $50.4 billion, up 0.7% from 3Q 2025. Diluted EPS was $6.27 and adjusted diluted EPS was $6.99.

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists are available without signing in.